Ferring’s Senior Vice President of R&D Planning and Technology Transfer leads the evaluation of R&D opportunities in pre-phase III development and consults with other relevant Ferring divisions. In addition, this unit leads the out-licensing process of Ferring's early stage compounds.
Currently, Ferring has one compound for out-licensing:
- A PTH analogue for osteoporosis
Please also contact the Senior Vice President of R&D Planning and Technology Transfer regarding search and transactions management:
Ferring International Center
Alan S. Harris
Senior Vice President Global R&D Projects and Portfolio
Phone: +41 58 301 00 00
alan.harris@ferring.com